The recent findings of DNA fragments in the Pfizer and Moderna COVID-19 vaccines has led many to question why the FDA, which is responsible for monitoring...
Questions about co-sleeping are often drowned out in a whirlwind of information and opinions. But science can provide some answers.
In a truly historic decision today, the U.S. Food and Drug Administration (FDA) has, as expected, approved Casgevy, the groundbreaking CRISPR-based gene...
The world’s first commercial gene-editing treatment is set to start changing the lives of people with sickle-cell disease. It’s called Casgevy, and...
Terran’s new patents cover new psilocybin forms, orally active DMT, and 5-MeO-DMT, and novel forms of ibogaine derivative tabernanthalog. The post Terran...
Potentially groundbreaking results as Cybin's Phase 2 Study of CYB003 in Major Depressive Disorder showed 79% of patients in remission after two 12mg doses. The...
For those interested in ketamine treatment, there is a vast array of potential therapies designed to meet you where you’re at.
A new review reveals that the substance is considered unsafe and should therefore be pulled from many popular products.
A five-year, $5 million grant has been awarded by the National Cancer Institute (NCI) to the UTHealth Houston Institute for Implementation Science to...
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”) is pleased to announce the successful resolution of a dispute...